Share：
Share this content in WeChat
X
[Chinese][PDF]90574
• Clinical Article •
Intravoxel incoherent motion diffusion weighted imaging and T1 mapping for the evaluation of autoimmune pancreatitis: a clinical study
CANG Lizhuo  ZHANG Xianyi  CAI Xiaoli  WANG Min  JI Ruoyun  SHI Yu 

Cite this article as: Cang LZ, Zhang XY, Cai XL, et al. Intravoxel incoherent motion diffusion weighted imaging and T1 mapping for the evaluation of autoimmune pancreatitis: a clinical study. Chin J Magn Reson Imaging, 2019, 10(7): 519-524. DOI:10.12015/issn.1674-8034.2019.07.008.


[Abstract] Objective: To evaluate the diagnostic performance of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) and T1 mapping for the evaluation of autoimmune pancreatitis (AIP).Materials and Methods: A total of 26 patients with AIP confirmed by pathology and clinical evaluation, 18 healthy volunteers and 39 patients with pancreatic cancer (PC) confirmed histologically underwent IVIM-DWI and T1 mapping with 9 different b values (0, 25, 75, 100, 150, 200, 500, 800 and 1000 s/mm2). The difference of T1 value and IVIM-DWI imaging parameters [true diffusion coefficient (D), pseudo-diffusion coefficient (D*), and perfusion fraction (f)] were analyzed between normal pancreas, PC and AIP groups. Receiver operating characteristic curve (ROC) analysis was performed to evaluate the diagnostic performance of the D, D* and f for differentiation between AIP and PC, and AIP and normal pancreas.Results: The mean f value in normal pancreas, PC and AIP was (20.6±4.2)%, (12.0±3.7)% and (9.1±3.1)%, respectively, with statistical difference among groups (P<0.001). The diagnostic performance of f value [area under the ROC curve (AUC) of 0.970 and 0.747, respectively] in differentiating normal pancreas from AIP, and AIP from PC was better than that of T1 value (AUC=0.949, 0.685), D (AUC: 0.513 and 0.582) and D* (AUC: 0.825 and 0.493).Conclusions: Perfusion fraction f by IVIM-DWI is a promising method in differential diagnosis of AIP.
[Keywords] pancreatitis；autoimmunity；magnetic resonance imaging

CANG Lizhuo Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China

ZHANG Xianyi Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China

CAI Xiaoli Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China

WANG Min Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China

JI Ruoyun Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China

SHI Yu* Department of Radiology, Shengjing Hospital, China Medical University, Shenyang 110004, China

*Correspondence to: Shi Y, E-mail: 18940259980@163.com

Conflicts of interest   None.

ACKNOWLEDGMENTS  This article is supported by the National Natural Science Foundation of China NO. 81771802, 81771893, 81471718 Liaoning Province Innovative Talent Support Program NO. LR2016020 Outstanding Youth Foundation of China Medical University NO. YQ20160005
Received  2019-01-13
Accepted  2019-04-20
DOI: 10.12015/issn.1674-8034.2019.07.008
Cite this article as: Cang LZ, Zhang XY, Cai XL, et al. Intravoxel incoherent motion diffusion weighted imaging and T1 mapping for the evaluation of autoimmune pancreatitis: a clinical study. Chin J Magn Reson Imaging, 2019, 10(7): 519-524. DOI:10.12015/issn.1674-8034.2019.07.008.

[1]
Raina A, Yadav D, Krasinskas AM, et al. Evaluation and management of autoimmune pancreatitis: experience at a large US center. Am J Gastroenterol, 2009, 104(9): 2295-2306.
[2]
Okazaki K, Tomiyama T, Mitsuyama T, et al. Diagnosis and classification of autoimmune pancreatitis. Autoimmun Rev, 2014, 13(4-5): 451-458.
[3]
Frulloni L, Scattolini C, Falconi M, et al. Autoimmune pancreatitis: differences between the focal and diffuse forms in 87 patients. Am J Gastroenterol, 2009, 104(9): 2288-2294.
[4]
Teixeira T, Hafyane T, Jerosch-Herold M, et al. Myocardial partition coefficient of gadolinium: a pilot study in patients with acute myocarditis, chronic myocardial infarction, and in healthy volunteers. Can J Cardiol, 2019, 35(1): 51-60.
[5]
Klauss M, Maier-Hein K, Tjaden C, et al. IVIM DW-MRI of autoimmune pancreatitis: therapy monitoring and differentiation from pancreatic cancer. Eur Radiol, 2016, 26(7): 2099-2106.
[6]
Okazaki K, Chari ST, Frulloni L, et al. International consensus for the treatment of autoimmune pancreatitis. Pancreatology, 2017, 17(1): 1-6.
[7]
Shimosegawa T, Working Group Members of the Japan Pancreas Society, Research Committee for Intractable Pancreatic Disease by the Ministry of Labor, Health and Welfare of Japan. The amendment of the Clinical Diagnostic Criteria in Japan (JPS2011) in response to the proposal of the International Consensus of Diagnostic Criteria (ICDC) for autoimmune pancreatitis. Pancreas, 2012, 41(8): 1341-1342.
[8]
Shimosegawa T, Chari ST, Frulloni L, et al. International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the International Association of Pancreatology. Pancreas, 2011, 40(3): 352-358.
[9]
Chari ST, Takahashi N, Levy MJ, et al. A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer. Clin Gastroenterol Hepatol, 2009, 7(10): 1097-1103.
[10]
Kamisawa T, Takuma K, Anjiki H, et al. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI. Am J Gastroenterol, 2010, 105(8): 1870-1875.
[11]
Hur BY, Lee JM, Lee JE, et al. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma. J Magn Reson Imaging, 2012, 36(1): 188-197.
[12]
Muhi A, Ichikawa T, Motosugi U, et al. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings. J Magn Reson Imaging, 2012, 35(4): 827-836.
[13]
Taniguchi T, Kobayashi H, Nishikawa K, et al. Diffusion-weighted magnetic resonance imaging in autoimmune pancreatitis. Jpn J Radiol, 2009, 27(3): 138-142.
[14]
Oki H, Hayashida Y, Oki H, et al. DWI findings of autoimmune pancreatitis: comparison between symptomatic and asymptomatic patients. J Magn Reson Imaging, 2015, 41(1): 125-131.
[15]
Manfredi R, Frulloni L, Mantovani W, et al. Autoimmune pancreatitis: pancreatic and extrapancreatic MR imaging-MR cholangiopancreatography findings at diagnosis, after steroid therapy, and at recurrence. Radiology, 2011, 260(2): 428-436.
[16]
Hu G, Liang W, Wu M, et al. Comparison of T1 mapping and T1rho values with conventional diffusion-weighted imaging to assess fibrosis in a rat model of unilateral ureteral obstruction. Acad Radiol, 2019, 26(1): 22-29.
[17]
Wang M, Gao F, Wang X, et al. Magnetic resonance elastography and T1 mapping for early diagnosis and classification of chronic pancreatitis. J Magn Reson Imaging, 2018,48(3): 837-845.
[18]
Luetkens JA, Klein S, Traber F, et al. Quantification of liver fibrosis at T1 and T2 mapping with extracellular volume fraction MRI: preclinical results. Radiology, 2018, 288(3): 748-754.

PREV The value of histogram-based apparent diffusion coefficient in distinguishing hepatocellular carcinoma from intrahepatic cholangiocarcinoma
NEXT Application of texture analysis in dynamic contrast-enhanced MRI for differentiation of renal cell carcinoma subtypes
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn